Inhibition of human leukocyte elastase activity by heparins: influence of charge density

Biochim Biophys Acta. 1996 Aug 13;1290(3):299-307. doi: 10.1016/0304-4165(96)00033-5.

Abstract

Heparins with different structures and physico-chemical properties were evaluated for their capacity to inhibit human leukocyte elastase activity in vitro by using a chromogenic substrate. Heparin from bovine intestinal mucosa and heparan sulfate from bovine spleen were extracted and purified, and their purity, structures, and physico-chemical properties were evaluated. Slow moving and fast moving heparin species were obtained by selective precipitation as barium salt, and partially desulfated and re-N-sulfated heparin was produced by chemical modifications. Heparins with different molecular mass (from 950 to 7820), narrow polydispersity and the same charge density were produced by a chemical depolymerization process in the presence of free radicals, and further gel-permeation chromatography. Heparins strongly inhibit elastase activity, and there is a significant linear dependence between charge density (sulfate-to-carboxyl ratio) and enzymatic activity. We also found a significant linear correlation between the percentage of N-sulfate groups and increased inhibition of elastase activity and between the percentage of iduronic acid and enzymatic activity. Heparin samples with a M(r) greater than about 2000-3000 inhibit the HLE activity to the same extent (about 59%) whilst two fractions with a M(r) of 1530 (29% inhibition of HLE activity) and 950 (4% inhibition of HLE activity) have less capacity to produce a decrease in the enzymatic activity.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cattle
  • Disaccharides / analysis
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology*
  • Glycosaminoglycans / chemistry
  • Glycosaminoglycans / pharmacology*
  • Heparin / chemistry
  • Heparin / pharmacology
  • Heparitin Sulfate / chemistry
  • Heparitin Sulfate / pharmacology
  • Humans
  • Leukocyte Elastase
  • Molecular Weight
  • Pancreatic Elastase / antagonists & inhibitors*
  • Potentiometry
  • Structure-Activity Relationship

Substances

  • Disaccharides
  • Enzyme Inhibitors
  • Glycosaminoglycans
  • Heparin
  • Heparitin Sulfate
  • Pancreatic Elastase
  • Leukocyte Elastase